Skip Navigation

AIDSInfo logo
173 studies were found.                 Refine search


Not yet recruitingDurability of Adherence in Self-Management of HIV (The DASH Study)
Condition: HIV Infections		En español
Not yet recruitingTelephone Support to Improve Adherence to Anti-HIV Medications
Condition: HIV Infections		En español
RecruitingSafety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents
Condition: HIV Infections		En español
RecruitingSafety and Effectiveness of Addition of Maraviroc to ART Regimens in HIV-Infected Adults With Suboptimal CD4 T-Cell Count Recovery Despite Sustained Virologic Suppression
Condition: HIV Infections		En español
RecruitingSafety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Condition: HIV Infections		En español
RecruitingSafety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Condition: HIV Infections; Hyperlipidemia		En español
Not yet recruitingDepletion of Latent HIV in CD4 Cells
Condition: HIV Infections		En español
RecruitingOptimizing Treatment for Treatment-Experienced, HIV-infected People
Condition: HIV Infections		En español
RecruitingObservational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections		En español
RecruitingSafety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV-Infected Children and Adolescents
Condition: HIV Infections		En español
RecruitingSafety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
Condition: HIV Infections		En español
RecruitingUsing Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Condition: HIV Infections		En español
RecruitingPharmacokinetic Study of Anti-HIV Drugs During Pregnancy
Condition: HIV Infections		En español
RecruitingPrenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Condition: HIV Infections; Pregnancy Complications, Infectious		En español
RecruitingLong-Term Data Collection From Participants in Adult AIDS Clinical Trials
Condition: HIV Infections		En español
RecruitingEffectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients
Condition: HIV Infections		En español
Not yet recruitingSafety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth
Condition: HIV Infections; H1N1 Influenza Virus
RecruitingOral Human Papillomavirus Infection in HIV-Infected Men
Condition: Papillomavirus Infections; HIV Infections
AvailableSafety Study of TMC-125 in HIV-Infected Children and Adolescents
Condition: HIV Infections
RecruitingThe St. Marys and The Mater Switch Study
Condition: HIV Infections
RecruitingA Randomized, Dose-Ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects
Condition: HIV Infections
RecruitingResearch on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Condition: Acquired Immune Deficiency Syndrome Virus; HIV Infections
RecruitingSafety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
Condition: HIV Infections
Not yet recruitingIntegrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
RecruitingTherapeutic Approaches to HAART-Induced Lipodystrophy
Condition: HIV Infections; Lipodystrophy
RecruitingIsoniazid Plus (Highly Active Antiretroviral Therapy) HAART to Prevent Tuberculosis (TB) in HIV-Infected Persons
Condition: Tuberculosis; Latent Tuberculosis Infection; HIV Infections
RecruitingLopinavir/Ritonavir (Kaletra)PK
Condition: HIV/AIDS Treatment; HIV Infections
RecruitingPhase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Condition: HIV Infections
RecruitingStudy of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infections
Not yet recruitingStudy of Bone Disease in Older HIV-infected Adults
Condition: Osteopenia; Osteoporosis; HIV Infection; Aging; HIV Infections
RecruitingPharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Condition: HIV Infection; HIV Infections
RecruitingLopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
Condition: HIV Infection; Lipodystrophy; HIV Infections
RecruitingEffect of Maraviroc on Endothelial Function in HIV-Infected Patients
Condition: HIV Infection; Endothelial Function; Cardiovascular Disease; Inflammation; HIV Infections
Not yet recruitingStudying Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Condition: Hematopoietic/Lymphoid Cancer; Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Childhood Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Recurrent Adult Acute Lymphoblastic Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Recurrent Childhood Acute Lymphoblastic Leukemia; Adult Acute Myeloid Leukemia in Remission; Recurrent Adult Acute Myeloid Leukemia; Childhood Acute Myeloid Leukemia in Remission; Recurrent Childhood Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Disease, Unclassifiable; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes; HIV-associated Hodgkin Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Adult Nasal Type Extranodal NK/T-cell Lymphoma; AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Burkitt Lymphoma; HIV Infections
RecruitingCCR5 Inhibitor Treatment Intensification on CD4+ T-Cell Recovery
Condition: HIV Infections
Not yet recruitingMaraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Not yet recruitingIntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients
Condition: HIV Infections
RecruitingRosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
Condition: Atherosclerosis; HIV Infections
RecruitingMaraviroc in Immunological Non-Responder (INR) HIV-1-Infected Subjects
Condition: HIV Infections
RecruitingLopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Condition: HIV Infections; Hepatitis C
RecruitingRaltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
Condition: HIV Infections
RecruitingRaltegravir Switch for Toxicity or Adverse Events
Condition: HIV/AIDS; Antiretroviral Therapy; HIV Infections
RecruitingHIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
RecruitingRaltegravir Therapy for Women With HIV and Fat Accumulation
Condition: HIV Infections; Lipodystrophy
RecruitingFanconi Syndrome Due to ARVs in HIV-Infected Persons
Condition: HIV Infections; Fanconi Syndrome; Kidney Disease; Renal Impairment
RecruitingImmunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)
Condition: HIV Infections
RecruitingWhite Blood Cell Infusion to Treat HIV Infection
Condition: HIV Infections
RecruitingStudy of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.
Condition: HIV-1 Infection; HIV Infections
RecruitingTreatment De-Intensification and Residual HIV-1 in Youth
Condition: HIV-1; HIV Infections
Not yet recruitingCoadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-Infected Patients
Condition: HIV; Hyperlipidemia; HIV Infections
RecruitingKaletra Monotherapy in HIV/HCV Co-Infected Subjects
Condition: HIV Infections
RecruitingProspective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Condition: HIV1 Infection; HIV Infections
RecruitingEffects of HIV and Hepatitis C Virus on the Brain
Condition: HIV Infections; Hepatitis C
RecruitingProspective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
RecruitingAn Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: HIV
Not yet recruitingTherapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Condition: HIV Infections; Treatment Experienced
AvailableEmergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment
Condition: HIV Infections
RecruitingPilot Study of a Raltegravir Based NRTI Sparing Regimen
Condition: Acquired Immune Deficiency Syndrome; AIDS; Human Immunodeficiency Virus; HIV Infections
RecruitingGrowth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Condition: HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; HIV Infections; Metabolic Syndrome X; Body Weight Changes
RecruitingA Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With TMC114r (Ritonavir), and TMC125 (Etravirine) in HIV-1 Infected Pregnant Women
Condition: HIV; HIV Infections; Pregnancy
RecruitingEffect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome
Condition: HIV (Human Immunodeficiency Virus); Metabolic Syndrome; HIV Infections
Not yet recruitingElizabeth Glaser Pediatric AIDS Foundation (EGPAF)Antiretroviral Pregnancy Registry A Multi-Site Protocol
Condition: HIV Infections; HIV Positive; Pregnant Women
RecruitingThe TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.
Condition: HIV-1
RecruitingTMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients
Condition: HIV Infections; Acquired Immunodeficiency Syndrome
RecruitingA Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Condition: HIV Infections
RecruitingPhase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Condition: HIV Infections
Not yet recruitingEfficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Condition: HIV Infection; Hemophilia A
Not yet recruitingTMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Condition: HIV Infections; HIV-1
RecruitingSafety Study of Lopinavir/Ritonavir With Raltegravir in HIV-Infected Patients
Condition: HIV Infections
RecruitingTMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
Condition: HIV Infections
RecruitingMulticenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
Condition: HIV Infection
RecruitingOnce Daily 3TC, Efavirenz and ddI for HIV Infection
Condition: HIV Infection; AIDS
RecruitingAdjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring
Condition: Human Immunodeficiency Virus; HIV Infections
Not yet recruitingEvaluation of Three Strategies of Second-Line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Condition: HIV; HIV Infections
Not yet recruitingEurope-Africa Research Network for Evaluation of Second-line Therapy
Condition: Human Immunodeficiency Virus; HIV Infections
RecruitingAutologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
Condition: HIV; HIV Infections
Not yet recruitingStatin Therapy to Improve Atherosclerosis in HIV Patients
Condition: Cardiovascular Disease; HIV; Atherosclerosis; Inflammation; Statins, HMG-CoA; HIV Infections
Not yet recruitingSwitch From Tenofovir to Raltegravir for Low Bone Mineral Density
Condition: HIV; Osteopenia; Osteoporosis; HIV Infections
RecruitingMyocardial Function & FFA Metabolism in HIV Metabolic Syndrome
Condition: HIV Infections; Cardiovascular Disease; Insulin Resistance; HIV Lipodystrophy; The Metabolic Syndrome
RecruitingA Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects
Condition: HIV-1 Infection; HIV Infections
RecruitingEquivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
Condition: Pediatric HIV; HIV Infections
RecruitingHuman Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT
Condition: Insulin Resistance; Atherosclerosis; Cardiovascular Disease; HIV/AIDS; HIV Infections
RecruitingTreatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
Condition: HIV/HCV co-Infection; HIV Infections
RecruitingSeroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Condition: HSV-2; HIV; HIV Infections
RecruitingReducing HIV Risks in African American Teens
Condition: HIV Infections Risk; HIV Infections
RecruitingSafety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
Condition: HIV Seropositivity; HIV Infection
Not yet recruitingPilot Assessment of Lopinavir/Ritonavir and Maraviroc
Condition: HIV Infections; Acquired Immunodeficiency Syndrome
Not yet recruitingEffect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Condition: HIV-1; HIV Infections
RecruitingEffect of Raltegravir on Endothelial Function in HIV-Infected Patients
Condition: HIV Infection; Inflammation; Cardiovascular Disease; Vascular Function; HIV Infections
RecruitingPharmacotherapy for HIV Infected Patients With Alcohol Problems
Condition: HIV Infection; Heavy Alcoholic Consumption; HIV Infections
RecruitingEpidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Condition: HIV Infection; Pulmonary Hypertension; Endothelial Function; HIV Infections
RecruitingPrevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
Condition: HIV Infection; HIV Infections
RecruitingStudy of Tests to Evaluate Effectiveness of Anti-HIV Drugs
Condition: HIV Infection
RecruitingVitamin D Reabsorption in Adolescents and Young Adults With HIV Infection
Condition: HIV Infections
RecruitingEffects of L-Carnitine on Postprandial Clearance of Triglyceride-Rich Lipoproteins in HIV Patients on HAART
Condition: Hyperlipidemia; HIV Infections
RecruitingADHEPTA Study: Adherence Questionnaire in Hepatitis C
Condition: Hepatitis C, Chronic; HIV Infection
RecruitingRetreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Condition: Liver Cirrhosis; Hepatitis C Virus; HIV Infection
RecruitingThe Effects of Nutritional Supplementation and Drug Abuse on HIV
Condition: HIV Infections; Substance-Related Disorders
Not yet recruitingPharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Condition: HIV Infections
RecruitingRaltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Condition: HIV Infections
RecruitingStudy to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
Condition: HIV Infections; Sexually Transmitted Diseases
RecruitingNon-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune
Condition: HIV Infections
RecruitingThe Detection of Drug-Resistant HIV-1 in Taiwan
Condition: HIV Infections
RecruitingSimplification From Protease Inhibitors to Raltegravir
Condition: HIV Infections
Not yet recruitingAtazanavir and Lamivudine for Treatment Simplification
Condition: HIV Infections
RecruitingMaraviroc Immune Recovery Study
Condition: HIV Infections
Not yet recruitingTreatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
Condition: Anxiety Disorders; HIV Infections
RecruitingRHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infections
RecruitingRaltegravir and Atazanavir Dosing Strategy Study
Condition: HIV Infection
RecruitingKaletra-Isentress Treatment Evaluation
Condition: HIV Infections
RecruitingPREventing Progression of Adipose Tissue Redistribution
Condition: HIV Infections
RecruitingEfficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients
Condition: Hepatitis B; HIV Infections
RecruitingDose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
Condition: HIV
Not yet recruitingStudy on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Condition: Acquired Immune Deficiency Syndrome; HIV Infections
RecruitingA Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
Condition: HIV-1
RecruitingIntegrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
RecruitingTMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents.
Condition: HIV-1
RecruitingCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Condition: Lymphoma
RecruitingPTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Condition: Precancerous/Nonmalignant Condition; Sarcoma
RecruitingHigh Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Condition: HIV; AIDS
RecruitingA Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Condition: HIV-1
RecruitingSunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy
Condition: Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol Specific
RecruitingHepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Condition: HIV Infections; Hepatitis A; Hepatitis B
RecruitingStudy of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
RecruitingThe Maraviroc Central Nervous System (CNS) Study
Condition: HIV Infections
Not yet recruitingA Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Condition: HIV Infections
Not yet recruitingMorphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane
Condition: Buttock Lipoatrophy; HIV Infections
RecruitingCardiovascular Prevention for Persons With HIV
Condition: HIV Infection; Cardiovascular Disease Risk
RecruitingHIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy
Condition: HIV-1 Infection
RecruitingStudy of Raltegravir Versus Nucleotide Reverse Transcriptase Inhibitors (NRTIs) as a Backbone in HIV-Infected Subjects Switched From a Stable Boosted Protease Inhibitor (PI) Regimen
Condition: HIV Infections
Not yet recruitingAdding Nitazoxanide to Treatment for People With Hepatitis C Virus and HIV Coinfection
Condition: HIV Infections; Hepatitis C Virus
RecruitingSwitching From PI to RALtegravir in HIV Stable Patients
Condition: HIV Infections
RecruitingSecond-Line Therapy Antiretroviral in Patients Who Failed Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
Condition: HIV Infections
RecruitingLopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
Condition: HIV Infections
Not yet recruitingProtease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Women
Condition: Malaria; HIV Infections
RecruitingPharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
RecruitingPredictors of Drug Hypersensitivity in HIV Infected Subjects
Condition: HIV Infections; Hypersensitivity
Not yet recruitingCotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Condition: HIV Infections
RecruitingPilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana
Condition: HIV Infections
Not yet recruitingRandomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
Condition: HIV Infections
Not yet recruitingPilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
Condition: HIV Infections
RecruitingA Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study
Condition: HIV Infections
RecruitingHIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infections
RecruitingArtery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
RecruitingAn Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Condition: HIV Infections; HCV
RecruitingHIV and Cardiovascular Risk
Condition: HIV Infections; Cardiovascular Disease
RecruitingEnhancing Oral Health Care Use by HIV Positive Individuals
Condition: Oral Hygiene; HIV Infections; Mouth Diseases
Not yet recruitingEvaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
Condition: HIV Infections
RecruitingIL-7 Receptor Polymorphisms and Immune Recovery With HAART
Condition: HIV Infections
RecruitingEffects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
Condition: HIV Infections; Insulin Resistance; Hyperlactatemia
RecruitingStudy to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Condition: HIV Infections
RecruitingKaletra Sex/Gender Pharmacokinetics (PK) Study: A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir
Condition: HIV Infections
Not yet recruitingPharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-Infected Adults
Condition: HIV Infections; Malaria
RecruitingA Prospective Cohort of Children With HIV Infection
Condition: HIV Infections
RecruitingROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
RecruitingONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla
Condition: HIV Infections
RecruitingProspective Longitudinal Pilot Study on the Effect of Intensification With Raltegravir +/- PI or NNRTI on HIV in the GALT
Condition: HIV Infections
RecruitingSHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Condition: HIV Infections; Lipodystrophy
Not yet recruitingClinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Condition: HIV Infections; Lipoatrophy
RecruitingLopinavir Capsules to Kaletra or Invirase Tablets
Condition: HIV Infections
Not yet recruitingEffect of Rosuvastatin on Cardiovascular Risk in HIV-Infected Individuals With Low High Density Lipoprotein (HDL) Cholesterol
Condition: HIV Infections; Cardiovascular Disease
RecruitingCCRC: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Raltegravir Therapy
Condition: HIV Infections; AIDS
RecruitingHepatitis B Vaccination (HBV) in HIV Infected Children
Condition: HIV Infections
Not yet recruitingPatient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz
Condition: Sleep Disorders; HIV Infections
RecruitingLINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Condition: HIV Infections; Diffuse Large B Cell Lymphoma
RecruitingEffects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
Condition: HIV Infections; Hypertension
RecruitingEntecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Condition: HIV Infections; Hepatitis B
RecruitingUse of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults
Condition: Insulin Resistance; HIV Infections
RecruitingKidney and Liver Transplantation in People With HIV
Condition: HIV Infections; Kidney Disease; Liver Disease
RecruitingHigh-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma
Condition: AIDS-Related Lymphoma; HIV Infections
RecruitingEffectiveness of Nucleoside Supplementation and Substituting Tenofovir Disoproxil Fumarate for Other Drugs in Anti-HIV Regimens in Reversing Fat Loss in HIV Infected Adults
Condition: HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
RecruitingLifestyle Modification and Metformin Use in the Treatment of HIV
Condition: HIV Infections; Metabolic Syndrome X
RecruitingComparing Raltegravir Genital Tract Distribution in HIV-Infected Men and Women
Condition: HIV Infections